Skip to main content
Rural Health Information Hub
Rural Health Information Hub

Rural Pharmacy and Prescription Drugs – News

News stories from the past 60 days.

Aug 3, 2026 - Notice from the Health Resources and Services Administration (HRSA) announcing the availability of a revised 340B Rebate Model Pilot Program (Pilot). The Pilot provides a rebate mechanism through which qualifying drug manufacturers may effectuate the 340B ceiling price for certain drugs sold to covered entities. Eligible manufacturers seeking to participate in the 340B Rebate Model Pilot Program must submit plans to 340BPricing@hrsa.gov by August 24, 2026, for an effective date of January 1, 2027.
Source: Federal Register
Jul 31, 2026 - Describes a heart failure care program in rural West Virginia pharmacies. The program includes care coordination between local pharmacists and cardiovascular specialists to support consistent care and identify medication-related concerns early for rural patients.
Source: WVU Medicine
Jul 31, 2026 - Announces the revised 340B Rebate Model Pilot Program to use a claims-based rebate approach. Eligible manufacturers must submit rebate plans by August 24, 2026 for pricing periods effective January 1, 2027.
Source: Health Resources & Services Administration
Jul 20, 2026 - Notice from the Centers for Medicare & Medicaid Services (CMS) seeking comments on draft guidance for the Medicare Drug Price Negotiation Program regarding manufacturer effectuation of the maximum fair price in 2028 for the implementation of the Inflation Reduction Act of 2022 (IRA). Comments are due by September 18, 2026.
Source: Federal Register
Jul 2, 2026 - Describes a pilot program using an at-home prescription drug dispensing unit to help rural Minnesota residents with mobility issues remain in their homes in spite of healthcare access challenges. The initiative was started following a community health needs assessment showing almost 50% of residents have difficulty accessing healthcare. The initiative is expanding to more communities.
Source: KAAL
Jun 29, 2026 - Describes proposed legislation that makes changes to the 340B Drug Pricing Program and requests feedback on the proposal. Comments are due by August 28, 2026.
Source: U.S. Senate Committee on Health, Education, Labor, and Pensions
Jun 22, 2026 - Notice from the Health Resources and Services Administration (HRSA) correcting the total number of responses listed in the June 15, 2026, notice.
Source: Federal Register
Jun 22, 2026 - Offers an interview with an independent pharmacy owner and the president of the Kansas Pharmacists Association. Discusses clinical services, sustainability, and recognizing community needs.
Source: Pharmacy Times
Jun 18, 2026 - The Centers for Medicare & Medicaid Services (CMS) is seeking comments on a request for information (RFI) regarding technical input on the services and business practices of pharmacy benefit managers (PBMs) and their affiliates to inform implementation of recent legislation. The RFI specifically focuses on two specific legislative requirements that are effective beginning calendar year 2028: 1) restrictions on the remuneration that PBMs and their affiliates may receive for services in connection with the utilization of covered Part D drugs and 2) data reporting requirements. Comments are due by July 20, 2026.
Source: Federal Register
Jun 16, 2026 - Notice of proposed rule from the Centers for Medicare & Medicaid Services (CMS) that would codify the Medicare Drug Price Negotiation Program, establish certain new policies for the Negotiation Program and the Medicare Prescription Drug Benefit Program as required by the Inflation Reduction Act of 2022, and propose a modification to the fixed combination drug policy. Comments are due by August 17, 2026.
Source: Federal Register